
News|Articles|July 1, 2003
Eszopiclone treats chronic insomnia without increasing dose
Results of a 6-month phase 3 trial using the non-benzodiazepine eszopiclone in 788 patients with chronic insomnia showed improved sleep maintenance versus placebo.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
Cancer survival fell and deaths rose during first two years of COVID-19
3
TrumpRx launches; some experts question its long-term value
4
PBM reform. It has finally happened
5























